SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-22-281196
Filing Date
2022-11-09
Accepted
2022-11-09 16:05:31
Documents
51
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d413250d10q.htm   iXBRL 10-Q 722772
2 EX-31.1 d413250dex311.htm EX-31.1 11369
3 EX-31.2 d413250dex312.htm EX-31.2 11375
4 EX-32.1 d413250dex321.htm EX-32.1 4503
5 EX-32.2 d413250dex322.htm EX-32.2 4437
  Complete submission text file 0001193125-22-281196.txt   3792892

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA flac-20220930.xsd EX-101.SCH 35432
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE flac-20220930_cal.xml EX-101.CAL 16494
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE flac-20220930_def.xml EX-101.DEF 186872
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE flac-20220930_lab.xml EX-101.LAB 230960
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE flac-20220930_pre.xml EX-101.PRE 227278
45 EXTRACTED XBRL INSTANCE DOCUMENT d413250d10q_htm.xml XML 537786
Mailing Address TWO UNION SQUARE, 601 UNION STREET SUITE 3200 SEATTLE WA 98101
Business Address TWO UNION SQUARE, 601 UNION STREET SUITE 3200 SEATTLE WA 98101 617-570-8364
Frazier Lifesciences Acquisition Corp (Filer) CIK: 0001828326 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39765 | Film No.: 221372505
SIC: 6770 Blank Checks